• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
AoUPRS: A cost-effective and versatile PRS calculator for the All of Us Program.AoUPRS:一款用于“我们所有人计划”的经济高效且通用的PRS计算器。
BMC Genomics. 2025 May 22;26(1):521. doi: 10.1186/s12864-025-11693-9.
2
AoUPRS: A Cost-Effective and Versatile PRS Calculator for the Program.AoUPRS:该项目一款经济高效且通用的PRS计算器。
bioRxiv. 2024 Jul 16:2024.07.11.603165. doi: 10.1101/2024.07.11.603165.
3
Precision Medicine in Cardiovascular Disease Prevention: Clinical Validation of Multi-Ancestry Polygenic Risk Scores in a U.S. Cohort.心血管疾病预防中的精准医学:美国队列中多血统多基因风险评分的临床验证
Nutrients. 2025 Mar 6;17(5):926. doi: 10.3390/nu17050926.
4
All of Us diversity and scale improve polygenic prediction contextually with greatest improvements for under-represented populations.“我们所有人”项目的多样性和规模在情境中改善了多基因预测,对代表性不足的人群改善最大。
bioRxiv. 2024 Aug 6:2024.08.06.606846. doi: 10.1101/2024.08.06.606846.
5
Additive Value of Polygenic Risk Score to Family History for Type 2 Diabetes Prediction: Results From the All of Us Research Database.多基因风险评分对2型糖尿病预测家族史的附加价值:来自“我们所有人”研究数据库的结果
Diabetes Care. 2025 Feb 1;48(2):212-219. doi: 10.2337/dc24-1537.
6
Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.基于人群的前瞻性队列研究:东亚常见癌症的多基因风险评分预测。
Elife. 2023 Mar 27;12:e82608. doi: 10.7554/eLife.82608.
7
Validating and automating learning of cardiometabolic polygenic risk scores from direct-to-consumer genetic and phenotypic data: implications for scaling precision health research.从直接面向消费者的遗传和表型数据中验证和自动化学习心血管代谢多基因风险评分:对精准健康研究扩展的影响。
Hum Genomics. 2022 Sep 8;16(1):37. doi: 10.1186/s40246-022-00406-y.
8
PRS-on-Spark (PRSoS): a novel, efficient and flexible approach for generating polygenic risk scores.PRS-on-Spark(PRSoS):一种新颖、高效且灵活的多基因风险评分生成方法。
BMC Bioinformatics. 2018 Aug 8;19(1):295. doi: 10.1186/s12859-018-2289-9.
9
Genomic insights for personalised care in lung cancer and smoking cessation: motivating at-risk individuals toward evidence-based health practices.肺癌个性化护理与戒烟的基因组学见解:激励高危个体采取循证健康行为。
EBioMedicine. 2024 Dec;110:105441. doi: 10.1016/j.ebiom.2024.105441. Epub 2024 Nov 8.
10
Performance of Polygenic Risk Scores for Primary Open-Angle Glaucoma in Populations of African Descent.非洲裔人群中原发性开角型青光眼多基因风险评分的表现
JAMA Ophthalmol. 2025 Jan 1;143(1):7-14. doi: 10.1001/jamaophthalmol.2024.4784.

本文引用的文献

1
Genomic data in the All of Us Research Program.全美国研究计划中的基因组数据。
Nature. 2024 Mar;627(8003):340-346. doi: 10.1038/s41586-023-06957-x. Epub 2024 Feb 19.
2
Polygenic Risk Score, Lifestyles, and Type 2 Diabetes Risk: A Prospective Chinese Cohort Study.多基因风险评分、生活方式与 2 型糖尿病风险:一项前瞻性中国队列研究。
Nutrients. 2023 Apr 29;15(9):2144. doi: 10.3390/nu15092144.
3
Type 2 Diabetes Polygenic Score Predicts the Risk of Glucocorticoid-Induced Hyperglycemia in Patients Without Diabetes.2 型糖尿病多基因风险评分可预测无糖尿病患者发生糖皮质激素诱导性高血糖的风险。
Diabetes Care. 2023 Aug 1;46(8):1541-1545. doi: 10.2337/dc23-0353.
4
Polygenic risk scores for cardiovascular diseases and type 2 diabetes.心血管疾病和 2 型糖尿病的多基因风险评分。
PLoS One. 2022 Dec 2;17(12):e0278764. doi: 10.1371/journal.pone.0278764. eCollection 2022.
5
The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation.多基因风险评分目录作为一个开放的数据库,用于可重复性和系统评估。
Nat Genet. 2021 Apr;53(4):420-425. doi: 10.1038/s41588-021-00783-5.
6
Population Bias in Polygenic Risk Prediction Models for Coronary Artery Disease.群体偏倚对冠状动脉疾病多基因风险预测模型的影响。
Circ Genom Precis Med. 2020 Dec;13(6):e002932. doi: 10.1161/CIRCGEN.120.002932. Epub 2020 Nov 10.
7
The "All of Us" Research Program.“All of Us”研究计划。
N Engl J Med. 2019 Aug 15;381(7):668-676. doi: 10.1056/NEJMsr1809937.
8
The personal and clinical utility of polygenic risk scores.多基因风险评分的个体和临床效用。
Nat Rev Genet. 2018 Sep;19(9):581-590. doi: 10.1038/s41576-018-0018-x.

AoUPRS:一款用于“我们所有人计划”的经济高效且通用的PRS计算器。

AoUPRS: A cost-effective and versatile PRS calculator for the All of Us Program.

作者信息

Khattab Ahmed, Chen Shang-Fu, Wineinger Nathan, Torkamani Ali

机构信息

Integrative Structural and Computational Biology, Scripps Research, La Jolla, CA, USA.

Scripps Research Translational Institute, 3344 North Torrey Pines Court, Suite 300, La Jolla, CA, 92037, USA.

出版信息

BMC Genomics. 2025 May 22;26(1):521. doi: 10.1186/s12864-025-11693-9.

DOI:10.1186/s12864-025-11693-9
PMID:40405064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12096765/
Abstract

BACKGROUND

The All of Us (AoU) Research Program provides a comprehensive genomic dataset to accelerate health research and medical breakthroughs. Despite its potential, researchers face significant challenges, including high costs and inefficiencies associated with data extraction and analysis. AoUPRS addresses these challenges by offering a versatile and cost-effective tool for calculating polygenic risk scores (PRS), enabling both experienced and novice researchers to leverage the AoU dataset for large-scale genomic discoveries.

METHODS

We evaluated three PRS models from the PGS Catalog (coronary artery disease, atrial fibrillation, and type 2 diabetes) using two distinct approaches in the Hail framework: MatrixTable (MT), a dense representation, and Variant Dataset (VDS), a sparse representation optimized for large-scale genomic data. Computational cost, resource usage, and processing time were compared. To assess the similarity of PRS performance between these two approaches, we compared odds ratios (ORs) and area under the curve (AUC). Lin's concordance correlation coefficient (CCC) was also computed to quantify agreement between PRS scores generated by MT and VDS.

RESULTS

The VDS approach reduced computational costs by up to 99.51% (e.g., from $32 to $0.036 for a 51-SNP score) while maintaining PRS estimates that were highly similar to those obtained using the MT approach. Across all three PRS models, AUC comparisons showed minimal differences between MT and VDS, indicating that both approaches yield consistent PRS performance. Agreement between PRS scores calculated by both approaches was further supported by Lin's CCC values ranging from 0.9199 to 0.9944, confirming strong concordance. Empirical cumulative distribution function (ECDF) plots further illustrated the near-identical distribution of PRS values across methods.

CONCLUSIONS

AoUPRS enables efficient and cost-effective PRS computation within AoU, providing substantial cost savings while maintaining highly consistent PRS estimates. These findings support the use of AoUPRS for large-scale genomic risk assessment, making the AoU dataset more accessible and practical for diverse research applications. The tool's open-source availability on GitHub, coupled with detailed documentation and tutorials, ensures accessibility and ease of use for the scientific community.

摘要

背景

“我们所有人”(AoU)研究计划提供了一个全面的基因组数据集,以加速健康研究和医学突破。尽管具有潜力,但研究人员面临重大挑战,包括与数据提取和分析相关的高成本和低效率。AoUPRS通过提供一种通用且经济高效的工具来计算多基因风险评分(PRS),使经验丰富和新手研究人员都能够利用AoU数据集进行大规模基因组发现,从而应对这些挑战。

方法

我们在Hail框架中使用两种不同的方法评估了PGS Catalog中的三种PRS模型(冠状动脉疾病、心房颤动和2型糖尿病):密集表示的矩阵表(MT)和针对大规模基因组数据优化的稀疏表示的变异数据集(VDS)。比较了计算成本、资源使用情况和处理时间。为了评估这两种方法之间PRS性能的相似性,我们比较了优势比(OR)和曲线下面积(AUC)。还计算了林氏一致性相关系数(CCC),以量化MT和VDS生成的PRS分数之间的一致性。

结果

VDS方法将计算成本降低了高达99.51%(例如,对于一个51个单核苷酸多态性的分数,从32美元降至0.036美元),同时保持了与使用MT方法获得的PRS估计值高度相似。在所有三种PRS模型中,AUC比较显示MT和VDS之间差异最小,表明两种方法产生的PRS性能一致。两种方法计算的PRS分数之间的一致性进一步得到林氏CCC值在0.9199至0.9944之间的支持,证实了高度一致性。经验累积分布函数(ECDF)图进一步说明了不同方法之间PRS值的几乎相同分布。

结论

AoUPRS能够在AoU内进行高效且经济高效的PRS计算,在保持高度一致的PRS估计值的同时节省大量成本。这些发现支持使用AoUPRS进行大规模基因组风险评估,使AoU数据集对各种研究应用更易于获取和实用。该工具在GitHub上的开源可用性,以及详细的文档和教程,确保了科学界能够访问并易于使用。